Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ra Pharmaceuticals
Biotech
UCB races to regulators after $2B rare disease bet delivers data
With the rare disease clinical trial hitting its primary endpoint, UCB is preparing to file to join AstraZeneca and argenx in a congested space.
Nick Paul Taylor
Feb 4, 2022 8:25am
Ex-Ra Pharma execs snag $75M for Curie's radiopharmaceuticals
Dec 1, 2021 9:45am
UCB strikes $2.5B deal to buy Ra for rival to Alexion's Soliris
Oct 10, 2019 7:35am
IPOs: Ra Pharma raises $92M, as Pfizer to gain rights to Myovant
Oct 26, 2016 9:43am
A pair of biotech IPOs line up: Myovant and Ra Pharma
Oct 3, 2016 10:59am
